DEXCOM, INC. Deferred Income Tax Expense (Benefit)
DEXCOM, INC. (DXCM) reported Deferred Income Tax Expense (Benefit) of -$300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-30
- DEXCOM, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$300.00K.
- DEXCOM, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $300.00K.
- DEXCOM, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $78.90M, a 224.69% increase year-over-year.
- DEXCOM, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $118.00M.
- DEXCOM, INC. deferred income tax expense (benefit) for fiscal 2025 was $182.20M.
- DEXCOM, INC. deferred income tax expense (benefit) for fiscal 2024 was -$43.80M.
- DEXCOM, INC. deferred income tax expense (benefit) for fiscal 2023 was -$55.00M.
- DEXCOM, INC. deferred income tax expense (benefit) for fiscal 2022 was -$21.60M, a 236.71% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$300.00K 10-Q · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | $78.90M derived: sum of 3 quarters · filed 2026-07-30 | $196.90M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $300.00K 10-Q · filed 2026-04-30 | $79.20M derived: sum of 2 quarters · filed 2026-04-30 | $197.20M derived: sum of 3 quarters · filed 2026-04-30 | $188.30M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $78.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $196.90M derived: sum of 2 quarters · filed 2026-02-12 | $188.00M derived: sum of 3 quarters · filed 2026-07-30 | $182.20M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $118.00M 10-Q · filed 2025-10-30 | $109.10M derived: sum of 2 quarters · filed 2026-07-30 | $103.30M 10-Q · filed 2025-10-30 | $127.60M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | -$8.90M 10-Q · filed 2026-07-30 | -$14.70M 10-Q · filed 2026-07-30 | $9.60M derived: sum of 3 quarters · filed 2026-07-30 | -$2.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | -$5.80M 10-Q · filed 2026-04-30 | $18.50M derived: sum of 2 quarters · filed 2026-04-30 | $6.90M derived: sum of 3 quarters · filed 2026-04-30 | -$7.80M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $24.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $12.70M derived: sum of 2 quarters · filed 2026-02-12 | -$2.00M derived: sum of 3 quarters · filed 2026-02-12 | -$43.80M 10-K · filed 2026-02-12 | |
| 2024-09-30 | -$11.60M 10-Q · filed 2025-10-30 | -$26.30M derived: sum of 2 quarters · filed 2025-10-30 | -$68.10M 10-Q · filed 2025-10-30 | $13.40M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-06-30 | -$14.70M 10-Q · filed 2025-07-30 | -$56.50M 10-Q · filed 2025-07-30 | $25.00M derived: sum of 3 quarters · filed 2026-02-12 | -$60.00M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-03-31 | -$41.80M 10-Q · filed 2025-05-01 | $39.70M derived: sum of 2 quarters · filed 2026-02-12 | -$45.30M derived: sum of 3 quarters · filed 2026-02-12 | -$87.50M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2023-12-31 | $81.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$3.50M derived: sum of 2 quarters · filed 2026-02-12 | -$45.70M derived: sum of 3 quarters · filed 2026-02-12 | -$55.00M 10-K · filed 2026-02-12 | |
| 2023-09-30 | -$85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | -$127.20M derived: sum of 2 quarters · filed 2024-10-24 | -$136.50M 10-Q · filed 2024-10-24 | -$104.50M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | -$42.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | -$51.50M 10-Q · filed 2024-07-25 | -$19.50M derived: sum of 3 quarters · filed 2025-02-18 | -$53.30M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | -$9.30M 10-Q · filed 2024-04-25 | $22.70M derived: sum of 2 quarters · filed 2025-02-18 | -$11.10M derived: sum of 3 quarters · filed 2025-02-18 | -$31.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$1.80M derived: sum of 2 quarters · filed 2025-02-18 | -$21.70M derived: sum of 3 quarters · filed 2025-02-18 | -$21.60M 10-K · filed 2025-02-18 | |
| 2022-09-30 | -$33.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$53.70M derived: sum of 2 quarters · filed 2023-10-26 | -$53.60M 10-Q · filed 2023-10-26 | -$38.00M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-06-30 | -$19.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$19.80M 10-Q · filed 2023-07-27 | -$4.20M derived: sum of 3 quarters · filed 2024-02-08 | -$4.10M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-04-27 | $15.70M derived: sum of 2 quarters · filed 2024-02-08 | $15.80M derived: sum of 3 quarters · filed 2024-02-08 | $16.20M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2021-12-31 | $15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $15.70M derived: sum of 2 quarters · filed 2024-02-08 | $16.10M derived: sum of 3 quarters · filed 2024-02-08 | $15.80M 10-K · filed 2024-02-08 | -$4.90M 10-K · filed 2022-02-14 |
| 2021-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $500.00K derived: sum of 2 quarters · filed 2022-10-27 | $200.00K 10-Q · filed 2022-10-27 | -$260.30M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $100.00K 10-Q · filed 2022-07-28 | -$260.40M derived: sum of 3 quarters · filed 2023-02-09 | -$260.40M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-03-31 | -$300.00K 10-Q · filed 2022-04-28 | -$260.80M derived: sum of 2 quarters · filed 2023-02-09 | -$260.80M derived: sum of 3 quarters · filed 2023-02-09 | -$260.80M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2020-12-31 | -$260.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$260.50M derived: sum of 2 quarters · filed 2023-02-09 | -$260.50M derived: sum of 3 quarters · filed 2023-02-09 | -$260.50M 10-K · filed 2023-02-09 | -$277.30M 10-K · filed 2021-02-11 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | ||||
| 2019-12-31 | $200.00K 10-K · filed 2022-02-14 | ||||
| 2018-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$2.20M derived: sum of 2 quarters · filed 2021-02-11 | -$2.20M 10-K · filed 2021-02-11 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-02-21 | -$1.10M derived: sum of 2 quarters · filed 2019-02-21 | $16.00M derived: sum of 3 quarters · filed 2019-02-21 | $0.00 10-K · filed 2020-02-13 | |
| 2017-09-30 | -$1.10M 10-Q · filed 2017-11-01 | $16.00M derived: sum of 2 quarters · filed 2017-11-01 | -$18.20M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $17.10M 10-Q · filed 2017-08-01 | -$17.10M 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$200.00K derived: sum of 2 quarters · filed 2019-02-21 | -$200.00K 10-K · filed 2019-02-21 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-01 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |